A clinical trial is underway that may provide women with a more accurate way to detect cervical cancer.
A calculator to help men and their doctors assess the risk of prostate cancer has had a major upgrade to enhance men's and their physicians' understanding of a man's risk of prostate cancer.
Dasatinib shows promise for treating skin, breast and several other cancers.
MRI detects 18.1 additional cancers after negative findings with mammography and ultrasonography per 1,000 women.
Data from two randomized controlled trials suggest that bisphosphonate use does not protect against postmenopausal breast cancer, according to research.
A large DNA analysis of people with and without pancreatic cancer has identified several new genetic markers that signal increased risk of developing the highly lethal disease, reported scientists.
Mutations in a gene that helps regulate when genes are switched on and off in cells have been found to cause rare cases of Wilms tumor, the most common kidney cancer occurring in children.
Hypersensitivity reactions are a classic and serious side effect of cetuximab.
A new analysis confirms that US lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age.
Despite potential risks, many Americans are still screened for cancers toward the end of their lives.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|